Related Experiment Videos
Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms
B Anger1, J W Janssen, H Schrezenmeier
1Department of Pediatrics II, University of Ulm, F.R.G.
Leukemia
|April 1, 1990
Summary
Chronic myeloproliferative disorders (c-MPD) in women often originate from a single multipotent hematopoietic stem cell, as shown by X-chromosome inactivation patterns. This clonality analysis aids in distinguishing primary MPDs from reactive conditions.
Area of Science:
- Hematology
- Genetics
- Oncology
Background:
- Chronic myeloproliferative disorders (c-MPD) are a group of diseases affecting blood cell production.
- Understanding the cellular origin of c-MPD is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the clonality of peripheral blood leukocytes in women with c-MPD.
- To determine if c-MPD arises from a multipotent hematopoietic stem cell.
- To assess the utility of clonal analysis in differentiating primary MPD from reactive processes.
Main Methods:
- Analysis of X-chromosome gene restriction fragment length polymorphisms (phosphoglycerate kinase and hypoxanthine phosphoribosyl transferase).
- Study included 48 women diagnosed with chronic myeloproliferative disorders.
- Cell separation techniques were employed for granulocyte and T lymphocyte fractions.
Main Results:
- 50% of patients were heterozygous for polymorphic loci, enabling clonality assessment.
- A monoclonal X-inactivation pattern was observed in 17 of 24 evaluable cases, including all idiopathic myelofibrosis (IMF) patients.
- Granulocytes showed monoclonal origin, while T lymphocytes were nonclonal in cell separation analyses, suggesting a stem cell origin for MPD.
Conclusions:
- The findings strongly suggest that the majority of chronic myeloproliferative disorders originate from multipotent hematopoietic stem cells.
- X-chromosome inactivation pattern analysis is a valuable tool for distinguishing primary MPD from reactive conditions.